Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Life Expectancy with Advanced Liver Fibrosis

Interpretation of Fibrosis Scores

  • A FIB-4 score of 1.83 falls in the intermediate risk range, suggesting possible significant fibrosis but not definitively indicating advanced fibrosis, according to the European Association for the Study of the Liver 1
  • An ELF score of 11.53 is well above the optimal cut-off of 9.8 for predicting adverse outcomes, indicating advanced fibrosis or cirrhosis, as recommended by the European Association for the Study of the Liver 3

Mortality Risk Assessment

  • The American Association for the Study of Liver Diseases recommends that liver-related mortality risk increases exponentially with fibrosis stage, with a 16.69-fold increase for F3 and a 42.30-fold increase for F4, as reported by the American Diabetes Association 6
  • The European Association for the Study of the Liver states that based on the ELF score of 11.53, which exceeds the 9.8 threshold, this patient has a high risk of liver-related mortality 3

Factors Affecting Prognosis

  • The American Gastroenterological Association notes that at 44 years old, this patient is relatively young, which is concerning as liver disease at a younger age is associated with more years of life lost 1
  • The presence of other risk factors such as diabetes, obesity, or ongoing alcohol consumption would further reduce life expectancy, according to the American Diabetes Association 6

Clinical Implications

  • The American Association for the Study of Liver Diseases recommends that this patient requires immediate referral to a hepatologist for comprehensive evaluation and management 8
  • The European Association for the Study of the Liver suggests that further assessment with vibration-controlled transient elastography (VCTE) or liver biopsy may be warranted to confirm the degree of fibrosis 4